Эбола, 2014 г. Эпидемиологические и социальные аспекты


Платонов А.Е., Платонова О.В., Малеев В.В.

Центральный НИИ эпидемиологии Роспотребнадзора, Москва
Эпидемия лихорадки Эбола, неожиданно начавшаяся зимой 2014 г. в Гвинее, к сентябрю охватила несколько стран Западной Африки. Уже заболело около 4 тыс. человек, более 2 тыс. из них умерло, в том числе, более 140 медицинских работников. Правительства Гвинеи, Сьерра-Леоне и, в особенности, Либерии признали огромный социально-экономический ущерб, нанесенный лихорадкой Эбола, и неспособность самостоятельно прекратить распространение инфекции. ВОЗ признала эпидемию «чрезвычайной угрозой здравоохранению, имеющей международное значение», требующей согласованных действий всего мирового сообщества. В обзоре приведены основные сведения об эпидемиологии, патогенезе, клинической картине и лечении лихорадки Эбола. Детально рассмотрены развитие эпидемии 2014 Г., социальные, экологические и эпидемиологические причины, обусловившие ее беспрецедентный масштаб. Обсуждаются проводимые и планируемые противоэпидемические мероприятия, а также прогнозы эпидемической ситуации и возможность использования «экспериментальных» профилактических и лечебных препаратов.

Литература


1. World Health Organization. Ebola virus disease. http://www.who.int/csr/disease/ebola/en/
2. Centers for Disease Control and Prevention. Ebola Hemorrhagic Fever. 2014. http://www.cdc.gov/vhf/ebola/index.html
3. European Centre for Disease Prevention and Control. Ebola and Marburg fevers. 2014. http://www.ecdc.europa.eu/en/healthtopics/ebola_marburg_fevers/Pages/index.aspx
4. Kuhn J.H., Bao Y., Bavari S. et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch. Virol. 2014; 159(5): 1229—1237.
5. Feldmann H., Geisbert T.W. Ebola haemorrhagic fever. Lancet 2011; 377(9768): 849—862.
6. Del Rio C., Mehta A.K., Lyon G.M. III, Guarner J. Ebola hemorrhagic fever in 2014: The tale of an evolving epidemic. Ann. Intern. Med. 2014 Aug 19. PubMed PMID: 25133433.
7. Olival K.J., Hayman D.T. Filoviruses in bats: current knowledge and future directions. Viruses 2014; 6(4): 1759—1788.
8. Leroy E.M., Kumulungui B., Pourrut X. et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438(7068): 575—576.
9. Bausch D.G., Schwarz L. Outbreak of ebola virus disease in Guinea: where ecology meets economy. PLoS Negl. Trop. Dis. 2014; 8(7): e3056.
10. Weingartl H.M., Nfon C., Kobinger G. Review of Ebola virus infections in domestic animals. Dev. Biol. (Basel) 2013; 135: 211—218.
11. Bermejo M., Rodriguez-Teijeiro J.D., Illera G. et al. Ebola outbreak killed 5000 gorillas. Science 2006; 314(5805): 1564.
12. O’Shea T.J., Cryan P.M., Cunningham A.A. et al. Bat flight and zoonotic viruses. Emerg. Infect. Dis. 2014; 20 (5): 741—745.
13. Tucker C.J., Wilson J.M., Mahoney R. et al. Climatic and ecological context of the 1994—1996 Ebola outbreaks. Photogrammetric Eng. Remote Sens. 2002; 68(2): 147—152.
14. Pinzon J.E., Wilson J.M., Tucker C.J. et al. Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks. Am. J. Trop. Med. Hyg. 2004; 71(5): 664—674.
15. Leroy E.M., Epelboin A., Mondonge V. et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis. 2009; 9(6): 723—728.
16. Becquart P., Wauquier N., Mahlakoiv T. et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 2010; 5(2): e9126.
17. Борисевич И.В., Маркин В.А., Фирсова И.В., Евсеев А.А., Хамитов Р.А., Максимов В.А. Эпидемиология, профилактика, клиника и лечение геморрагических лихорадок (Марбург, Эбола, Ласса и Боливийской). Вопр. вирусол. 2006; (5): 8—16.
18. Титенко А.М., Андаев Е.И. Научно-методологический подход к эпидемиологическому анализу и лабораторной диагностике болезней, вызванных вирусами Марбург и Эбола. Пробл. особо опасных инф. 2012; (3): 38—44.
19. Baize S., Pannetier D., Oestereich L. et al. Emergence of Zaire Ebola Virus Disease in Guinea — Preliminary Report. N. Engl. J. Med. 2014 Apr 16. PubMed PMID: 24738640.
20. Акинфеева Л.А., Аксенова О.И., Василевич И.В., Гинько З.И., Зарьков К.А. и др. Случай вирусной геморрагической лихорадки Эбола. Инфекц. бол. 2005; 3(1): 85—88.
21. World Health Organization. Ebola virus disease. Fact sheet N°103. Updated April 2014. http://www.who.int/mediacentre/factsheets/fs103/en/
22. Lefebvre A., Fiet C., Belpois-Duchamp C. et al. Case fatality rates of Ebola virus diseases: A meta-analysis of World Health Organization data. Med. Mal. Infect. 2014). http://dx.doi.org/10.1016/j.medmal.2014.08.005
23. Ng S., Basta N.E., Cowling B.J. Association between temperature, humidity and ebolavirus disease outbreaks in Africa, 1976 to 2014. Euro Surveill. 2014; 19(35): pii=20892.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20892
24. Tambo E., Ugwu E.C., Ngogang J.Y. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect. Dis. Poverty 2014; 3: 29.
25. Jezek Z., Szczeniowski M.Y., Muyembe-Tamfum J.J. et al. Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981-1985. J. Infect. Dis. 1999; 179(Suppl 1): S60—S64.
26. MacNeil A., Farnon E.C., Morgan O.W. et al. Filovirus outbreak detection and surveillance: lessons from Bundibugyo. J. Infect. Dis. 2011; 204(Suppl 3): S761—S767.
27. Richards G.A., Murphy S., Jobson R. et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit. Care Med. 2000; 28(1): 240—244.
28. Legrand J., Grais R.F., Boelle P.Y. et al. Understanding the dynamics of Ebola epidemics. Epidemiol. Infect. 2007; 135(4): 610—621.
29. Chowell G., Hengartner N.W., Castillo-Chavez C. et al. The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J. Theor. Biol. 2004; 229(1): 119—126.
30. Briand S., Bertherat E., Cox P. et al. The International Ebola Emergency. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140855.
31. Frieden T.R., Damon I., Bell B.P. et al. Ebola 2014 — new challenges, new global response and responsiblity. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140858.
32. Eichner M., Dowell S.F., Firese N. Incubation period of Ebola hemorrhagic virus subtype Zaire. Osong. Public Health Res. Perspect. 2011; 2(1): 3—7.
33. Платонов А.Е., Малеев В.В., Карань Л.С., Санникова И.В., Пасечников В.Д., Платонова О.В. и др. Крымская геморрагическая лихорадка в Евразии в XXI веке: клиника и диагностика. Эпидемиол. и инфекц. болезни. Актуал. вопр. 2012; (5): 45—54.
34. Kortepeter M.G., Bausch D.G., Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J. Infect. Dis. 2011; 204(Suppl 3): 810—816.
35. Maron D.F. Ebola doctor reveals how infected Americans were cured. Nature News 2014; doi:10.1038/nature.2014.15791 http://www.nature.com/news/ebola-doctor-reveals-how-infected-americans-were-cured-1.15791
36. Leroy E.M., Baize S., Volchkov V.E. et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355(9222): 2210—2215.
37. Leroy E.M., Baize S., Debre P. et al. Early immune responses accompanying human asymptomatic Ebola infections. Clin. Exp. Immunol. 2001; 124(3): 453—460.
38. Куличенко А.Н., Малецкая О.В., Василенко Н.Ф., Бейер А.П., Санникова И.В., Пасечников В.Д. и др. Крымская геморрагическая лихорадка в Евразии в XXI веке: эпидемиологические аспекты. Эпидемиол. инфекц. болезни. Актуал. вопр. 2012; (3): 42—53.
39. Torjesen I. Two doctors die from Ebola and lives of others under threat in West Africa. BMJ 2014; 349: g4895.
40. Платонов А.Е., Малеев В.В., Санникова И.В., Пасечников В.Д., Карань Л.С., Платонова О.В., Куличенко А.Н. Крымская геморрагическая лихорадка в Евразии в XXI веке: вопросы патогенеза и лечения. Эпидемиол. и инфекц. болезни. Актуал. вопр. 2012; (6): 46—58.
41. Reardon S. Ebola treatments caught in limbo. Nature 2014; 511 (7511): 520.
42. Warren T.K., Wells J., Panchal R.G. et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014; 508(7496): 402—405.
43. Wong G., Qiu X., Olinger G.G., Kobinger G.P. Post-exposure therapy of filovirus infections. Trends Microbiol. 2014; 22(8): 456—463.
44. Olinger G.G. Jr., Pettitt J., Kim D. et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl. Acad. Sci. USA 2012; 109(44): 18030—18035.
45. Rowe A.K., Bertolli J., Khan A.S. et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 1999; 179(Suppl 1): S28—S35.
46. Kucharski A.J., Piot P. Containing Ebola virus infection in West Africa. Euro Surveill. 2014;19(36):pii=20899. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20899
47. World Health Organization. Ebola situation in Liberia: non-conventional interventions needed. http://who.int/mediacentre/news/ebola/8-september-2014/en/
48. World Health Organization. Ebola Response Roadmap Situation Report 1. 29 August 2014. http://www.who.int/csr/disease/ebola/situation-reports/29-august-2014.pdf?ua=1
49. World Health Organization. Ebola Response Roadmap Situation Report 3. http://apps.who.int/iris/bitstream/10665/133073/1/roadmapsitrep3_eng.pdf?ua=1
50. World Health Organization. Virological analysis: no link between Ebola outbreaks in west Africa and Democratic Republic of Congo. http://who.int/mediacentre/news/ebola/2-september-2014/en/#
51. World Health Organization. Ebola virus disease — Democratic Republic of Congo. http://who.int/csr/don/2014_09_10_ebola/en/
52. Li Y.H., Chen S.P. Evolutionary history of Ebola virus. Epidemiol. Infect. 2014; 142(6): 1138—1145.
53. Carroll S.A., Towner J.S., Sealy T.K. et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J. Virol. 2013; 87(5): 2608—2616.
54. Wittmann T.J., Biek R., Hassanin A. et al. Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants. Proc. Natl. Acad. Sci. USA 2007; 104(43): 17123—17127.
55. Gire S.K., Goba A., Andersen K.G. et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014. http://www.sciencemag.org/content/early/2014/08/27/science.1259657.full.pdf
56. Dudas G., Rambaut A. Phylogenetic analysis of Guinea 2014 EBOV Ebolavirus outbreak. PLoS Curr. 2014; 6. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024086/
57. Calvignac-Spencer S., Schulze J.M., Zickmann F., Renard B.Y. Clock rooting further demonstrates that Guinea 2014 EBOV is a member of the Zaire lineage. PLoS Curr. 2014; 6. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073806/
58. Vogel G. Genomes reveal start of Ebola outbreak. Science 2014; 345(6200): 989—990.
59. Hayden E.C. Ebola virus mutating rapidly as it spreads. Outbreak likely originated with a single animal-to-human transmission. Nature 2014. http://www.nature.com/news/ebola-virus-mutating-rapidly-as-it-spreads-1.15777
60. Schoepp R.J., Rossi C.A., Khan S.H. et al. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg. Infect. Dis. 2014; 20(7): 1176—1182.
61. Chan M. Ebola virus disease in West Africa — No early end to the outbreak. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140856.
62. World Health Organization. Unprecedented number of medical staff infected with Ebola. http://www.who.int/mediacentre/news/ebola/25-august-2014/en/#
63. Gulland A. Health ministers in west Africa hold crisis talks on Ebola virus. BMJ 2014; 348: g4478.
64. World Health Organization. Ebola situation in Port Harcourt, Nigeria. http://who.int/mediacentre/news/ebola/3-september-2014/en/#
65. Gomes M.F.C., Pastore y Piontti A., Rossi L. et al. Assessing the international spreading risk associated with the 2014 West African Ebola outbreak. PLOS Currents Outbreaks 2014; Sep 2. Edition 1. doi: 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5.
66. Klompas M., Diekema D.J., Fishman N.O., Yokoe D.S. Ebola fever: reconciling Ebola planning with Ebola risk in U.S. hospitals. Ann. Intern. Med. 2014 Aug 21. PubMed PMID: 25141883.
67. Centers for Disease Control and Prevention. Health Alert Network HAN 368: CDC Ebola Response Update #4. 2014. http://emergency.cdc.gov/han/han00368.asp
68. Роспотребнадзор. О ситуации с лихорадкой Эбола. 2014. http://rospotrebnadzor.ru/region/210fz/index.php
69. Роспотребнадзор. Рекомендации для медицинских работников по геморрагической лихорадке Эбола. 2014. http://rospotrebnadzor.ru/files/o-rekomendatsiyakh-po-likhoradke-ebola.pdf
70. Dowell S.F., Mukunu R., Ksiazek T.G. et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 1999; 179(Suppl 1): S87—S91.
71. Francesconi P., Yoti Z., Declich S. et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg. Infect. Dis. 2003; 9(11): 1430—1437.
72. Bausch D.G., Towner J.S., Dowell S.F. et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J. Infect. Dis. 2007; 196(Suppl 2): S142—S147.
73. European Centre for Disease Prevention and Control. Outbreak of Ebola virus disease in West Africa. Fourth update, 3 September 2014. Stockholm: ECDC. 2014. http://www.ecdc.europa.eu/en/publications/Publications/Ebola-virus-disease-west-africa-risk-assessment-27-08-2014.pdf
74. Ijaz K., Kasowski E., Arthur R.R. et al. International Health Regulations--what gets measured gets done. Emerg. Infect. Dis. 2012; 18(7): 1054—1057.
75. World Health Organization. Ebola Response Roadmap http://apps.who.int/iris/bitstream/10665/131596/1/EbolaResponseRoadmap.pdf
76. Nishiura H., Chowell G. Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014. Euro Surveill. 2014; 19(36): pii=20894. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20894
77. Fisman D., Khoo E., Tuite A. Early epidemic dynamics of the West African 2014 Ebola outbreak: estimates derived with a simple two-parameter model. PLOS Currents Outbreaks 2014; Sep 8. Edition 1. doi: 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571.
78. Althaus C.L. Estimating the reproduction number of Ebola virus (EBOV) during the 2014 outbreak in West Africa. PLOS Currents Outbreaks 2014; Sep. 2. Edition 1. doi: 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288
79. Gostin L.O., Lucey D., Phelan A. The Ebola epidemic: a global health emergency. JAMA 2014 Aug 11. PubMed PMID: 25111044.
80. Hirschberg R., Ward L.A., Kilgore N. et al. Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop. Viruses 2014; 6(7): 2673—2697.
81. Marzi A., Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert. Rev. Vaccines 2014; 13(4): 521—531.
82 . Galvani A.P., Ndeffo-Mbah M.L., Wenzel N., Childs J.E. Ebola vaccination: If not now, when? Ann. Intern. Med. 2014 Aug 21. PubMed PMID: 25141813.
83. Goodman J.L. Studying «Secret Serums» — Toward Safe, Effective Ebola Treatments. N. Engl. J. Med. 2014 Aug 20. PubMed PMID: 25140857.
84. Qiu X., Wong G., Audet J. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014; doi: 10.1038/nature13777. http://www.nature.com/nature/journal/vnfv/ncurrent/pdf/nature13777.pdf
85. World Health Organization. Ethical considerations for use of unregistered interventions for Ebola virus disease Report of an advisory panel to WHO. http://www.who.int/csr/resources/publications/ebola/ethical-considerations/en/
86. World Health Organization. Statement on the WHO Consultation on potential Ebola therapies and vaccines. http://who.int/mediacentre/news/statements/2014/ebola-therapies-consultation/en/#
87. Uebelhoer L.S., Albarino C.G., McMullan L.K. et al. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Antiviral Res. 2014; 106: 86—94.
88. Enserink M. Infectious diseases. Debate erupts on ’repurposed’ drugs for Ebola. Science 2014; 345(6198): 718—719.
89. Johansen L.M., Brannan J.M., Delos S.E. et al. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci. Transl. Med. 2013; 5(190): 190ra79. doi:10.1126/scitranslmed.3005471.
90. Kass N. Ebola, ethics, and public health: what next? Ann. Intern. Med. 2014 Aug 19. PubMed PMID: 25133473.
91. Arie S. Ebola: an opportunity for a clinical trial? BMJ 2014; 349: g4997.
92. Интерфакс. Обама отправит в Африку три тысячи военнослужащих на борьбу с вирусом Эбола. http://www.interfax.ru/world/396919
93. UN News Centre. UN Security Council to hold emergency meeting on Ebola crisis. http://www.un.org/apps/news/story.asp?NewsID=48715#.VBg9l_1xm1Z
94. McNamara T., Platonov A., Elleman T., Gresham L. The human-animal interface and zoonotic threats: the Russian Federation approach. Biosecur. Bioterror. 2013; 11(3): 185—195.


Об авторах / Для корреспонденции


Для корреспонденции:
Платонов Александр Евгеньевич — д-р биол. наук, проф., зав лаб. эпидемиологии природно-очаговых инфекций Центрального НИИ эпидемиологии Роспотребнадзора
Адрес: 111123, Москва, ул. Новогиреевская, д. 3а
Телефон: +7(495) 974-96-46
E-mail: platonov@pcr.ru

Сведения об авторах:
Платонова Ольга Владимировна — науч. сотр. лаб. эпидемиологии природно-очаговых инфекций Центрального НИИ эпидемиологии Роспотребнадзора; oplatonova@pcr.ru
Малеев Виктор Васильевич — акад. РАН, д-р мед. наук, проф., зам. дир. по научно-исследовательской работе Центрального НИИ эпидемиологии Роспотребнадзора; maleyev@pcr.ru


Похожие статьи


Бионика Медиа